|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300071706 |
|
最近更新日期: Date of Last Refreshed on: |
2023-05-23 10:26:34 |
|
注册时间: Date of Registration: |
2023-05-23 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
微种植体脱落的影响因素分析及应对策略研究 |
|
Public title: |
A study on influencing factors of mini-implant failure and its coping strategies |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
微种植体脱落的影响因素分析及应对策略研究 |
|
Scientific title: |
A study on influencing factors of mini-implant failure and its coping strategies |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘鑫 |
研究负责人: |
刘鑫 |
|
Applicant: |
Liu Xin |
Study leader: |
Liu Xin |
|
申请注册联系人电话: Applicant telephone: |
+86 139 9197 9267 |
研究负责人电话:
Study leader's |
+86 139 9197 9267 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
986922403@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
986922403@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
陕西省西安市新城区长乐西路145号 |
研究负责人通讯地址: |
陕西省西安市新城区长乐西路145号 |
|
Applicant address: |
No. 145, Changle West Road, Xincheng District, Xi'an, Shanxi, China |
Study leader's address: |
No. 145, Changle West Road, Xincheng District, Xi'an, Shanxi, China |
|
申请注册联系人邮政编码: Applicant postcode: |
710032 |
研究负责人邮政编码: Study leader's postcode: |
710032 |
|
申请人所在单位: |
空军军医大学第三附属医院 |
||
|
Applicant's institution: |
The Third Affiliated Hospital of Air Force Military Medical University |
||
|
研究负责人所在单位: |
空军军医大学第三附属医院 |
||
|
Affiliation of the Leader: |
The Third Affiliated Hospital of Air Force Military Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KQ-YJ-2023-011 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
空军军医大学第三附属医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of the Third Affiliated Hospital of Air Force Military Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-02-23 00:00:00 | ||
|
伦理委员会联系人: |
成黎霏 |
||
|
Contact Name of the ethic committee: |
Cheng Lifei |
||
|
伦理委员会联系地址: |
陕西省西安市新城区长乐西路145号 |
||
|
Contact Address of the ethic committee: |
No. 145, Changle West Road, Xincheng District, Xi'an, Shanxi, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 29 8477 6082 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
空军军医大学第三附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Third Affiliated Hospital of Air Force Military Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
陕西省西安市新城区长乐西路145号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 145, Changle West Road, Xincheng District, Xi'an, Shanxi, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家口腔疾病临床医学研究中心重点课题 |
||||||||||||||||||||||
|
Source(s) of funding: |
Critical program of the National Clinical Research Center for Oral Diseases |
||||||||||||||||||||||
|
研究疾病: |
错颌畸形 |
||||||||||||||||||||||
|
Target disease: |
Malocclusion |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
历史对照研究 |
||||||||||||||||||||||
|
Study design: |
Historical control |
||||||||||||||||||||||
|
研究目的: |
研发颊侧、腭侧及颧牙槽嵴区微种植体植入导板,并在多个研究中心将其应用于临床,对导板植入的准确性、操作的便捷性进行检验,进一步优化导板设计,提高微种植体植入成功率。 |
||||||||||||||||||||||
|
Objectives of Study: |
To fabricate surgical guides for buccal, palatal and infrazygomatic mini-implants insertion, and apply them in orthodontic clinic in several research centers to investigate the accuracy and actionability, so as to further improvement in the guide design and the success rate of mini-implant placement. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.18-45岁,性别不限;2. 需在颊侧、腭侧或颧牙槽嵴区植入微种植体的患者;3. 牙周健康,不吸烟,能严格进行口腔卫生维护;4. 植入区骨量可,附着龈宽度足够;5. 身体健康,生长发育正常。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Age 18-45 years old; 2. Patients who need mini-implants insertion in the buccal, palatal and infrazygomatic crest areas; 3. Good periodontal health and oral hygiene maintenance, no smoking; 4. Adequate bone mass in the implantation area, and sufficient width of the attached gingiva; 5. Good health and normal growth. |
||||||||||||||||||||||
|
排除标准: |
1. 近3月内接受可能影响骨代谢药物治疗的患者;2. 患有影响骨代谢疾病的患者;3. 阿替卡因肾上腺素注射液过敏;4. 依从性较差,不能按时复诊的患者;5. 孕妇或哺乳期女性,近期有生育计划的育龄妇女;6. 精神异常无行为自主能力; 7. 金属过敏。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Medicine history related to bone metabolism in recent 3 months; 2. Bone metabolism related diseases; 3. Have a history of allergy to articaine epinephrine injection; 4. Bad compliance and subsequent visit can not be achieved on schedule; 5. Pregnant or breastfeeding women, women of childbearing age with recent childbirth plans; 6. Mental abnormality without behavioral autonomy; 7. Be allergic to metals. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-06-01 00:00:00至 To 2026-01-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-06-01 00:00:00 至 To 2025-07-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
文章发表后,向通讯作者申请 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
After the article is published, apply to the corresponding author |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |